• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETLW1613C93E
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Occlusion (1984); Pain (1994)
Date of Event 02/10/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii limb was implanted in a patient for the endovascular treatment of an isolated dilation of the right iliac artery.It was reported the patient presented emergently with leg pain.A ct angiogram showed the stent graft limb was occluded.A thrombectomy of the stent graft was carried out on along with the endovascular repair of the patient¿s abdominal aortic aneurysm.An angio-jet thrombectomy device was used to remove the acute thrombus and an endurant iis bifurcated stent graft was placed at the lowest right accessory renal artery.The indwelling stent graft was then married to the bifurcated stent graft with another 16x 13 limb.A 16x16 limb was also placed from the bifurcated stent graft to the left common iliac artery.The stent graft was ballooned and no endoleak was present on the post implantation angiogram.The event was reported to be resolved.As per the physician, the patient stopped taking their blood thinning medication and this led to the occlusion of the stent graft.No additional clinical sequelae were reported and the patient is fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key8389483
Report Number2953200-2019-00309
Device Sequence Number11157073
Product Code MIH
UDI-Device Identifier00643169467682
UDI-Public00643169467682
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/06/2020
Device Model NumberETLW1613C93E
Device Catalogue NumberETLW1613C93E
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/10/2019
Initial Report FDA Received Date03/05/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age66 YR
-
-